[{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_d3622f59db7ca8cad98b7104","course_id":"PHMSCI 757","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","record_version_id":"0a5ce5c007b8ee8b3b2b9d15956dbcbf774a5af76ec85d1eb39775666e636a3e","job_id":"enrich-5291a20b802b9bbbe22b24cb","output_id":"6b01e841a3ec2fcc6fe0f5bbfa4f07fe6f068f0576a15d7fa5ff595a16b40dc4","section":"requirements","status":"needs_review","value_json":"{\"nodes\":[{\"children\":[],\"condition\":\"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation\",\"course\":null,\"evidence\":\"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation\",\"id\":\"n0\",\"kind\":\"condition\"}],\"notes\":[\"Unlinked course mention: 'MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation' is not in linked_courses.\"],\"root\":\"n0\",\"status\":\"needs_review\"}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_d3622f59db7ca8cad98b7104","course_id":"PHMSCI 757","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","record_version_id":"0a5ce5c007b8ee8b3b2b9d15956dbcbf774a5af76ec85d1eb39775666e636a3e","job_id":"enrich-5291a20b802b9bbbe22b24cb","output_id":"6b01e841a3ec2fcc6fe0f5bbfa4f07fe6f068f0576a15d7fa5ff595a16b40dc4","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 757\",\"field\":\"requirements_text\",\"quote\":\"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation\"}],\"text\":\"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation\"}],\"search_phrases\":[\"drug development process\",\"clinical trials\",\"neurological diseases\",\"pharmaceutical sciences\",\"drug discovery\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 757\",\"field\":\"description\",\"quote\":\"Scientific process of drug development from discovery through clinical trials\"}],\"text\":\"Understanding the scientific process of drug development from discovery through clinical trials\"},{\"evidence\":[{\"course_id\":\"PHMSCI 757\",\"field\":\"description\",\"quote\":\"Application to real-world drug development scenarios and challenges\"}],\"text\":\"Applying drug development knowledge to real-world scenarios and challenges\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 757\",\"field\":\"title\",\"quote\":\"INTRODUCTION TO DRUG DEVELOPMENT\"},{\"course_id\":\"PHMSCI 757\",\"field\":\"description\",\"quote\":\"Scientific process of drug development from discovery through clinical trials\"}],\"text\":\"Introduction to the scientific process of drug development from discovery through clinical trials, with a focus on neurological diseases.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 757\",\"field\":\"description\",\"quote\":\"Brief history of drug development\"}],\"text\":\"History of drug development\"},{\"evidence\":[{\"course_id\":\"PHMSCI 757\",\"field\":\"description\",\"quote\":\"overview of drug discovery, preclinical, and clinical activities\"}],\"text\":\"Drug discovery, preclinical, and clinical activities\"},{\"evidence\":[{\"course_id\":\"PHMSCI 757\",\"field\":\"description\",\"quote\":\"development of drugs to treat neurological diseases\"}],\"text\":\"Development of drugs for neurological diseases\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_d3622f59db7ca8cad98b7104","course_id":"PHMSCI 757","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","record_version_id":"0a5ce5c007b8ee8b3b2b9d15956dbcbf774a5af76ec85d1eb39775666e636a3e","job_id":"enrich-5291a20b802b9bbbe22b24cb","output_id":"6b01e841a3ec2fcc6fe0f5bbfa4f07fe6f068f0576a15d7fa5ff595a16b40dc4","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_d3622f59db7ca8cad98b7104","course_id":"PHMSCI 757","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","record_version_id":"0a5ce5c007b8ee8b3b2b9d15956dbcbf774a5af76ec85d1eb39775666e636a3e","job_id":"enrich-5590a4969e0a630fe46a86e8","output_id":"91b53eab1e981f6441d3ce588fb3636da8defe2885667460bd4105baf46c294e","section":"requirements","status":"needs_review","value_json":"{\"nodes\":[{\"children\":[],\"condition\":\"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation\",\"course\":null,\"evidence\":\"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation\",\"id\":\"n0\",\"kind\":\"condition\"}],\"notes\":[\"Unlinked course mention: 'MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation' is not in linked_courses.\"],\"root\":\"n0\",\"status\":\"needs_review\"}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_d3622f59db7ca8cad98b7104","course_id":"PHMSCI 757","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","record_version_id":"0a5ce5c007b8ee8b3b2b9d15956dbcbf774a5af76ec85d1eb39775666e636a3e","job_id":"enrich-5590a4969e0a630fe46a86e8","output_id":"91b53eab1e981f6441d3ce588fb3636da8defe2885667460bd4105baf46c294e","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 757\",\"field\":\"requirements_text\",\"quote\":\"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation\"}],\"text\":\"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation\"}],\"search_phrases\":[\"drug development process\",\"clinical trials\",\"neurological diseases\",\"pharmaceutical sciences\",\"drug discovery\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 757\",\"field\":\"description\",\"quote\":\"Scientific process of drug development from discovery through clinical trials\"}],\"text\":\"Understanding the scientific process of drug development from discovery through clinical trials\"},{\"evidence\":[{\"course_id\":\"PHMSCI 757\",\"field\":\"description\",\"quote\":\"Application to real-world drug development scenarios and challenges\"}],\"text\":\"Applying drug development knowledge to real-world scenarios and challenges\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 757\",\"field\":\"title\",\"quote\":\"INTRODUCTION TO DRUG DEVELOPMENT\"},{\"course_id\":\"PHMSCI 757\",\"field\":\"description\",\"quote\":\"Scientific process of drug development from discovery through clinical trials\"}],\"text\":\"Introduction to the scientific process of drug development from discovery through clinical trials, with a focus on neurological diseases.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 757\",\"field\":\"description\",\"quote\":\"Brief history of drug development\"}],\"text\":\"History of drug development\"},{\"evidence\":[{\"course_id\":\"PHMSCI 757\",\"field\":\"description\",\"quote\":\"overview of drug discovery, preclinical, and clinical activities\"}],\"text\":\"Drug discovery, preclinical, and clinical activities\"},{\"evidence\":[{\"course_id\":\"PHMSCI 757\",\"field\":\"description\",\"quote\":\"development of drugs to treat neurological diseases\"}],\"text\":\"Development of drugs for neurological diseases\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_d3622f59db7ca8cad98b7104","course_id":"PHMSCI 757","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","record_version_id":"0a5ce5c007b8ee8b3b2b9d15956dbcbf774a5af76ec85d1eb39775666e636a3e","job_id":"enrich-5590a4969e0a630fe46a86e8","output_id":"91b53eab1e981f6441d3ce588fb3636da8defe2885667460bd4105baf46c294e","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_d3622f59db7ca8cad98b7104","course_id":"PHMSCI 757","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","record_version_id":"0a5ce5c007b8ee8b3b2b9d15956dbcbf774a5af76ec85d1eb39775666e636a3e","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"ab21a20080a9d440894085979374a1de4fe7433104f8e3500691c307dada8699","section":"requirements","status":"needs_review","value_json":"{\"nodes\":[{\"children\":[],\"condition\":\"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation\",\"course\":null,\"evidence\":\"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation\",\"id\":\"n0\",\"kind\":\"condition\"}],\"notes\":[\"Unlinked course mention: 'MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation' is not in linked_courses.\"],\"root\":\"n0\",\"status\":\"needs_review\"}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_d3622f59db7ca8cad98b7104","course_id":"PHMSCI 757","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","record_version_id":"0a5ce5c007b8ee8b3b2b9d15956dbcbf774a5af76ec85d1eb39775666e636a3e","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"ab21a20080a9d440894085979374a1de4fe7433104f8e3500691c307dada8699","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 757\",\"field\":\"requirements_text\",\"quote\":\"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation\"}],\"text\":\"Declared in MS Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation\"}],\"search_phrases\":[\"drug development process\",\"clinical trials\",\"neurological diseases\",\"pharmaceutical sciences\",\"drug discovery\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 757\",\"field\":\"description\",\"quote\":\"Scientific process of drug development from discovery through clinical trials\"}],\"text\":\"Understanding the scientific process of drug development from discovery through clinical trials\"},{\"evidence\":[{\"course_id\":\"PHMSCI 757\",\"field\":\"description\",\"quote\":\"Application to real-world drug development scenarios and challenges\"}],\"text\":\"Applying drug development knowledge to real-world scenarios and challenges\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 757\",\"field\":\"title\",\"quote\":\"INTRODUCTION TO DRUG DEVELOPMENT\"},{\"course_id\":\"PHMSCI 757\",\"field\":\"description\",\"quote\":\"Scientific process of drug development from discovery through clinical trials\"}],\"text\":\"Introduction to the scientific process of drug development from discovery through clinical trials, with a focus on neurological diseases.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 757\",\"field\":\"description\",\"quote\":\"Brief history of drug development\"}],\"text\":\"History of drug development\"},{\"evidence\":[{\"course_id\":\"PHMSCI 757\",\"field\":\"description\",\"quote\":\"overview of drug discovery, preclinical, and clinical activities\"}],\"text\":\"Drug discovery, preclinical, and clinical activities\"},{\"evidence\":[{\"course_id\":\"PHMSCI 757\",\"field\":\"description\",\"quote\":\"development of drugs to treat neurological diseases\"}],\"text\":\"Development of drugs for neurological diseases\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_d3622f59db7ca8cad98b7104","course_id":"PHMSCI 757","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","record_version_id":"0a5ce5c007b8ee8b3b2b9d15956dbcbf774a5af76ec85d1eb39775666e636a3e","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"ab21a20080a9d440894085979374a1de4fe7433104f8e3500691c307dada8699","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_d3622f59db7ca8cad98b7104","course_id":"PHMSCI 757","catalog_version_id":"5c607a4d78c7daa599a59b97ed897e05397a91d1fd93d83ad8af0624bc8122f1","record_version_id":"0a5ce5c007b8ee8b3b2b9d15956dbcbf774a5af76ec85d1eb39775666e636a3e","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"ab21a20080a9d440894085979374a1de4fe7433104f8e3500691c307dada8699","section":"student_summary","status":"valid","value_json":"{\"context_hash\":\"c7e5f8b8b85b5e80ad136ecb751040c427c52c4de000da79af8a75f6f537a668\",\"course_id\":\"PHMSCI 757\",\"current_instructors\":[{\"instructor_uid\":\"instructor_34a4ecc1734759ceaa76be18\",\"message\":\"No course-specific reviews available\",\"name\":\"Ardala Katzfuss\",\"review_status\":\"no_course_reviews\",\"rmp_instructor_id\":null,\"summary\":[]},{\"instructor_uid\":\"instructor_3aea62525aeb86c5fbe4025b\",\"message\":\"No course-specific reviews available\",\"name\":\"Leslie Dickmann\",\"review_status\":\"no_course_reviews\",\"rmp_instructor_id\":null,\"summary\":[{\"citations\":[{\"course_id\":\"PHMSCI 757\",\"run_id\":\"20260907T155543-ce3781c4\",\"section_number\":1,\"source_course_id\":\"7202b893-fa95-3fda-b735-d29f0a8236be\",\"source_record\":{\"entity_id\":\"7202b893-fa95-3fda-b735-d29f0a8236be\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1242\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 757\",\"run_id\":\"20260907T155543-ce3781c4\",\"section_number\":1,\"source_course_id\":\"7202b893-fa95-3fda-b735-d29f0a8236be\",\"source_record\":{\"entity_id\":\"7202b893-fa95-3fda-b735-d29f0a8236be\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1252\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 757\",\"run_id\":\"20260907T155543-ce3781c4\",\"section_number\":1,\"source_course_id\":\"7202b893-fa95-3fda-b735-d29f0a8236be\",\"source_record\":{\"entity_id\":\"7202b893-fa95-3fda-b735-d29f0a8236be\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1262\",\"type\":\"grade\"}],\"text\":\"Recent recorded grades — Fall 2023: 3.97 GPA, 100.0% A/AB (n=54 letter grades); Fall 2024: 3.90 GPA, 93.5% A/AB (n=31 letter grades); Fall 2025: 3.96 GPA, 100.0% A/AB (n=51 letter grades).\"}]}],\"difficulty_workload\":[],\"errors\":[],\"historical_context\":[],\"message\":\"No course-specific reviews available\",\"offered\":true,\"profile_hash\":\"5cb4dabf887cdbcd8c00d5a1312e10828b95c63f30bc3ea76aea199565390d02\",\"quick_take\":[{\"citations\":[{\"course_id\":\"PHMSCI 757\",\"run_id\":\"20260907T155543-ce3781c4\",\"source_record\":{\"entity_id\":\"7202b893-fa95-3fda-b735-d29f0a8236be\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"grades_latest\",\"term_id\":\"1242\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 757\",\"run_id\":\"20260907T155543-ce3781c4\",\"source_record\":{\"entity_id\":\"7202b893-fa95-3fda-b735-d29f0a8236be\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"grades_latest\",\"term_id\":\"1252\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 757\",\"run_id\":\"20260907T155543-ce3781c4\",\"source_record\":{\"entity_id\":\"7202b893-fa95-3fda-b735-d29f0a8236be\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"grades_latest\",\"term_id\":\"1262\",\"type\":\"grade\"}],\"text\":\"Recent recorded grades — Fall 2023: 3.97 GPA, 100.0% A/AB (n=54 letter grades); Fall 2024: 3.90 GPA, 93.5% A/AB (n=31 letter grades); Fall 2025: 3.96 GPA, 100.0% A/AB (n=51 letter grades).\"}],\"student_experience\":[],\"task_hash\":\"74fb0997943e888960bbc9e47db8c4fd12e4292d55c20509d8d89db6a9910f68\",\"teaching_history\":[{\"citations\":[{\"course_id\":\"PHMSCI 757\",\"run_id\":\"20260907T155543-ce3781c4\",\"section_number\":1,\"source_course_id\":\"7202b893-fa95-3fda-b735-d29f0a8236be\",\"source_record\":{\"entity_id\":\"7202b893-fa95-3fda-b735-d29f0a8236be\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1264\",\"type\":\"grade\"}],\"text\":\"ARDALA KATZFUSS is recorded teaching in Spring 2026. Recorded history may be incomplete and does not establish a future schedule.\"},{\"citations\":[{\"course_id\":\"PHMSCI 757\",\"run_id\":\"20260907T155543-ce3781c4\",\"section_number\":1,\"source_course_id\":\"7202b893-fa95-3fda-b735-d29f0a8236be\",\"source_record\":{\"entity_id\":\"7202b893-fa95-3fda-b735-d29f0a8236be\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1242\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 757\",\"run_id\":\"20260907T155543-ce3781c4\",\"section_number\":1,\"source_course_id\":\"7202b893-fa95-3fda-b735-d29f0a8236be\",\"source_record\":{\"entity_id\":\"7202b893-fa95-3fda-b735-d29f0a8236be\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1252\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 757\",\"run_id\":\"20260907T155543-ce3781c4\",\"section_number\":1,\"source_course_id\":\"7202b893-fa95-3fda-b735-d29f0a8236be\",\"source_record\":{\"entity_id\":\"7202b893-fa95-3fda-b735-d29f0a8236be\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1262\",\"type\":\"grade\"},{\"course_id\":\"PHMSCI 757\",\"run_id\":\"20260907T155543-ce3781c4\",\"section_number\":1,\"source_course_id\":\"7202b893-fa95-3fda-b735-d29f0a8236be\",\"source_record\":{\"entity_id\":\"7202b893-fa95-3fda-b735-d29f0a8236be\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"section_grades_latest\",\"term_id\":\"1264\",\"type\":\"grade\"}],\"text\":\"LESLIE DICKMANN is recorded teaching in Fall 2023, Fall 2024, Fall 2025, Spring 2026. Recorded history may be incomplete and does not establish a future schedule.\"}],\"term_id\":\"1272\",\"term_name\":\"2026 Fall\",\"version\":2}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true}]